Company Information

SUNIL HEALTHCARE LTD.

NSE : NABSE : 537253ISIN CODE : INE671C01016Industry : ChemicalsHouse : Private
BSE63.053 (+5 %)
PREV CLOSE ( ) 60.05
OPEN PRICE ( ) 63.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5440
TODAY'S LOW / HIGH ( )58.55 63.05
52 WK LOW / HIGH ( ) 45.6580
NSE
This Company is not listed in NSE
ChairmanAnil Khaitan
Managing DirectorAnil Khaitan
Company SecretarySatyendu Pattnaik
Non Executive Independent DirectorRakesh Mohan
Harish Pal Kumar
Bejon Kumar Misra
Mudita Chaturvedi
Non Independent & Non Executive DirectorSanjay Kumar Kaushik
Krishna Venkatachalam Rajan
Incorporation Year : 1973

Registered Office :

Address : 38 E / 252 - A , Vijay Tower,Panchsheel Commercial Complex,Shahpurjat New Delhi,
Delhi-110049 .

Phone : 011-49435555/00

Industry : Chemicals

Listing : BSE,Kolkata

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.